IL-1R8 negatively regulates cancer-related inflammation in intestinal carcinogenesis [81, 89], chronic lymphocytic leukemia (CLL) [90], and diffuse-large B-cell lymphoma [91]. The gene discussed is SIGIRR; the disease is cancer.